Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neutropenia 3Neoplasms 2Infections 2Hematologic Neoplasms 2Febrile Neutropenia 2Urinary Tract Infections 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Pneumonia 1Pain 1Migraine Disorders 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Intraabdominal Infections 1Influenza, Human 1Inflammation 1Hypokalemia 1Hypertension 1

Interventions

Vancomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Early Stage Non-Small Cell Lung Cancer × Vancomycin × Clear all
NCT03546829 2026-01-14

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Abramson Cancer Center at Penn Medicine

Phase 1 Recruiting
10 enrolled
Thoracic

Early Stage Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡